Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Flores

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Neuro-Oncology|December 29, 2019
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivoMyriam Jaraíz-Rodríguez, Rocío Talaverón, Laura García-Vicente, et al.
Development (Cambridge, England)|November 25, 2025
N2B27 media formulations influence gastruloid developmentTina Balayo, Sharna Lunn, Pau Pascual-Mas, et al.
Neuro-Oncology|March 20, 2024
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma modelsAndrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, et al.
Healthcare (Basel, Switzerland)|June 19, 2024
Exercise and Quality of Life (QoL) in Patients Undergoing Active Breast Cancer Treatment-Comparison of Three Modalities of a 24-Week Exercise Program-A Randomized Clinical TrialMaría-Pilar Suárez-Alcázar, M-Elena García-Roca, Eladio J Collado-Boira, et al.
Ebiomedicine|November 30, 2020
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43<sub>266-283</sub>Sara G Pelaz, Myriam Jaraíz-Rodríguez, Andrea Álvarez-Vázquez, et al.
Nutricion Hospitalaria|July 24, 2020
[Anxiety in the presence of food in schoolchildren of Baja California Sur]Andrea Socorro Álvarez-Villaseñor, Uriel Flores Osuna, Juana Sara Torres Barrera, et al.
Healthcare (Basel, Switzerland)|July 26, 2024
Prehabilitation Consultation on Self-Care and Physical Exercise in Patients Diagnosed with Abdominopelvic Cancer: Protocol of the StudyMaría Pilar Suárez-Alcázar, Eladio J Collado-Boira, Paula Recacha-Ponce, et al.
Healthcare (Basel, Switzerland)|June 26, 2024
Implementation of Nurse Prescriptions throughout the Public Health System in Catalonia (2021-2022)Rosa Bayot I Escardívol, Enric Mateo-Viladomat, Paola Galbany-Estragués, et al.
Communications Biology|April 28, 2025
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastomaLaura García-Vicente, María Martínez-Fernández, Michael Borja, et al.
Neuro-Oncology Advances|February 27, 2026
The Src inhibitor peptide TAT-Cx43<sub>266-283</sub> improves survival in an intracranial murine model of lung cancer brain metastasisPilar Cerveró-García, Enrique Jiménez-Madrona, Andrea Álvarez-Vázquez, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|December 29, 2019
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivoMyriam Jaraíz-Rodríguez, Rocío Talaverón, Laura García-Vicente, et al.
Development (Cambridge, England)|November 25, 2025
N2B27 media formulations influence gastruloid developmentTina Balayo, Sharna Lunn, Pau Pascual-Mas, et al.
Neuro-Oncology|March 20, 2024
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma modelsAndrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, et al.
Healthcare (Basel, Switzerland)|June 19, 2024
Exercise and Quality of Life (QoL) in Patients Undergoing Active Breast Cancer Treatment-Comparison of Three Modalities of a 24-Week Exercise Program-A Randomized Clinical TrialMaría-Pilar Suárez-Alcázar, M-Elena García-Roca, Eladio J Collado-Boira, et al.
Ebiomedicine|November 30, 2020
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43<sub>266-283</sub>Sara G Pelaz, Myriam Jaraíz-Rodríguez, Andrea Álvarez-Vázquez, et al.
Nutricion Hospitalaria|July 24, 2020
[Anxiety in the presence of food in schoolchildren of Baja California Sur]Andrea Socorro Álvarez-Villaseñor, Uriel Flores Osuna, Juana Sara Torres Barrera, et al.
Healthcare (Basel, Switzerland)|July 26, 2024
Prehabilitation Consultation on Self-Care and Physical Exercise in Patients Diagnosed with Abdominopelvic Cancer: Protocol of the StudyMaría Pilar Suárez-Alcázar, Eladio J Collado-Boira, Paula Recacha-Ponce, et al.
Healthcare (Basel, Switzerland)|June 26, 2024
Implementation of Nurse Prescriptions throughout the Public Health System in Catalonia (2021-2022)Rosa Bayot I Escardívol, Enric Mateo-Viladomat, Paola Galbany-Estragués, et al.
Communications Biology|April 28, 2025
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastomaLaura García-Vicente, María Martínez-Fernández, Michael Borja, et al.
Neuro-Oncology Advances|February 27, 2026
The Src inhibitor peptide TAT-Cx43<sub>266-283</sub> improves survival in an intracranial murine model of lung cancer brain metastasisPilar Cerveró-García, Enrique Jiménez-Madrona, Andrea Álvarez-Vázquez, et al.
Pageof 6